Jouni Hayan, Askew J Wells, Crusan Daniel J, Miller Todd D, Gibbons Raymond J
From the Department of Cardiovascular Diseases (H.J., J.W.A., T.D.M., R.J.G.) and Division of Biostatistics, Department of Health Sciences Research (D.J.C.), Mayo Clinic, Rochester, MN.
Circ Cardiovasc Imaging. 2017 Jul;10(7). doi: 10.1161/CIRCIMAGING.116.005628.
There has been a gradual decline in the prevalence of abnormal stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging studies among patients without history of coronary artery disease (CAD). The trends of SPECT studies among patients with known CAD have not been evaluated previously.
We assessed the Mayo Clinic nuclear cardiology database for all stress SPECT tests performed between January 1991 and December 2012 in patients with history of CAD defined as having previous myocardial infarction, percutaneous coronary intervention, and coronary artery bypass grafting. The study cohort was divided into 5 time periods: 1991 to 1995, 1996 to 2000, 2001 to 2005, 2006 to 2010, and 2011 to 2012. There were 19 373 patients with a history of CAD who underwent SPECT between 1991 and 2012 (mean age, 66.2±10.9 years; 75.4% men). Annual utilization of SPECT in these patients increased from an average of 495 tests per year in 1991 to 1995 to 1425 in 2003 and then decreased to 552 tests in 2012 without evidence for substitution with other stress modalities. Asymptomatic patients initially increased until 2006 and then decreased. Patients with typical angina decreased, whereas patients with dyspnea and atypical angina increased. High-risk SPECT tests significantly decreased, and the percentage of low-risk SPECT tests increased despite decreased SPECT utilization between 2003 and 2012. Almost 80% of all tests performed in 2012 had a low-risk summed stress score compared with 29% in 1991 (<0.001).
In Mayo Clinic, Rochester, annual SPECT utilization in patients with previous CAD increased between 1992 and 2003, but then decreased after 2003. High-risk SPECT tests declined, whereas low-risk tests increased markedly. Our results suggest that among patients with a history of CAD, SPECT was being increasingly utilized in patients with milder CAD. This trend parallels reduced utilization of other stress modalities, coronary angiography, reduced smoking, and greater utilization of optimal medical therapy for prevention and treatment of CAD.
在无冠状动脉疾病(CAD)病史的患者中,异常应激单光子发射计算机断层扫描(SPECT)心肌灌注成像研究的患病率呈逐渐下降趋势。此前尚未评估已知CAD患者中SPECT研究的趋势。
我们评估了梅奥诊所核心脏病学数据库中1991年1月至2012年12月期间对有CAD病史患者进行的所有应激SPECT检查,CAD病史定义为既往有心肌梗死、经皮冠状动脉介入治疗和冠状动脉旁路移植术。研究队列分为5个时间段:1991年至1995年、1996年至2000年、2001年至2005年、2006年至2010年以及2011年至2012年。1991年至2012年期间有19373例有CAD病史的患者接受了SPECT检查(平均年龄66.2±10.9岁;男性占75.4%)。这些患者中SPECT的年使用量从1991年至1995年的平均每年495次检查增加到2003年的1425次,然后在2012年降至552次,且无证据表明被其他应激方式替代。无症状患者最初增加,直至2006年,然后减少。典型心绞痛患者减少,而呼吸困难和非典型心绞痛患者增加。高风险SPECT检查显著减少,尽管2003年至2012年期间SPECT使用量减少,但低风险SPECT检查的百分比增加。与1991年的29%相比,2012年进行的所有检查中近80%的应激总分较低(<0.001)。
在罗切斯特的梅奥诊所,既往有CAD的患者中SPECT的年使用量在1992年至2003年期间增加,但2003年后下降。高风险SPECT检查减少,而低风险检查显著增加。我们的结果表明,在有CAD病史的患者中,SPECT越来越多地用于病情较轻的CAD患者。这一趋势与其他应激方式、冠状动脉造影的使用减少、吸烟减少以及预防和治疗CAD的最佳药物治疗的使用增加相平行。